These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 28709937)

  • 21. Calculated indices of volatile organic compounds (VOCs) in exhalation for lung cancer screening and early detection.
    Chen X; Muhammad KG; Madeeha C; Fu W; Xu L; Hu Y; Liu J; Ying K; Chen L; Yurievna GO
    Lung Cancer; 2021 Apr; 154():197-205. PubMed ID: 33653598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breathprinting and Early Diagnosis of Lung Cancer.
    Rocco G; Pennazza G; Santonico M; Longo F; Rocco R; Crucitti P; Antonelli Incalzi R
    J Thorac Oncol; 2018 Jul; 13(7):883-894. PubMed ID: 29526822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in the early detection of lung cancer using analysis of volatile organic compounds: from imaging to sensors.
    Li W; Liu HY; Jia ZR; Qiao PP; Pi XT; Chen J; Deng LH
    Asian Pac J Cancer Prev; 2014; 15(11):4377-84. PubMed ID: 24969857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discrimination of COPD and lung cancer from controls through breath analysis using a self-developed e-nose.
    Binson VA; Subramoniam M; Mathew L
    J Breath Res; 2021 Aug; 15(4):. PubMed ID: 34243176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multi-centre prospective study on diagnosing subtypes of lung cancer by exhaled-breath analysis.
    Kort S; Tiggeloven MM; Brusse-Keizer M; Gerritsen JW; Schouwink JH; Citgez E; de Jongh FHC; Samii S; van der Maten J; van den Bogart M; van der Palen J
    Lung Cancer; 2018 Nov; 125():223-229. PubMed ID: 30429025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breath testing as a method for detecting lung cancer.
    Taivans I; Bukovskis M; Strazda G; Jurka N
    Expert Rev Anticancer Ther; 2014 Feb; 14(2):121-3. PubMed ID: 24467216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Novel Framework with High Diagnostic Sensitivity for Lung Cancer Detection by Electronic Nose.
    Lu B; Fu L; Nie B; Peng Z; Liu H
    Sensors (Basel); 2019 Dec; 19(23):. PubMed ID: 31817006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EGFR mutation frequency and effectiveness of erlotinib: a prospective observational study in Danish patients with non-small cell lung cancer.
    Weber B; Hager H; Sorensen BS; McCulloch T; Mellemgaard A; Khalil AA; Nexo E; Meldgaard P
    Lung Cancer; 2014 Feb; 83(2):224-30. PubMed ID: 24388704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of volatile organic compounds in exhaled breath to screen lung cancer: a systematic review.
    Hua Q; Zhu Y; Liu H
    Future Oncol; 2018 Jul; 14(16):1647-1662. PubMed ID: 29939068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How well does your e-nose detect cancer? Application of artificial breath analysis for performance assessment.
    Martin JDM; Claudia F; Romain AC
    J Breath Res; 2024 Jan; 18(2):. PubMed ID: 38211310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exhaled Breath Analysis for Monitoring Response to Treatment in Advanced Lung Cancer.
    Nardi-Agmon I; Abud-Hawa M; Liran O; Gai-Mor N; Ilouze M; Onn A; Bar J; Shlomi D; Haick H; Peled N
    J Thorac Oncol; 2016 Jun; 11(6):827-37. PubMed ID: 26968885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lung Cancer Screening Based on Type-different Sensor Arrays.
    Li W; Liu H; Xie D; He Z; Pi X
    Sci Rep; 2017 May; 7(1):1969. PubMed ID: 28512336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic Factors for Survival After Recurrence in Patients With Completely Resected Lung Adenocarcinoma: Important Roles of Epidermal Growth Factor Receptor Mutation Status and the Current Staging System.
    Kudo Y; Shimada Y; Saji H; Kato Y; Yoshida K; Matsubayashi J; Nagase S; Kakihana M; Kajiwara N; Ohira T; Nagao T; Ikeda N
    Clin Lung Cancer; 2015 Nov; 16(6):e213-21. PubMed ID: 25986624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of plasma and tissue samples in epidermal growth factor receptor mutation by ARMS in advanced non-small cell lung cancer.
    Ma M; Shi C; Qian J; Teng J; Zhong H; Han B
    Gene; 2016 Oct; 591(1):58-64. PubMed ID: 27370697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutation and polymorphism in the EGFR-TK domain associated with lung cancer.
    Zhang W; Stabile LP; Keohavong P; Romkes M; Grandis JR; Traynor AM; Siegfried JM
    J Thorac Oncol; 2006 Sep; 1(7):635-47. PubMed ID: 17409930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of the EGFR mutation in exhaled breath condensate from a heavy smoker with squamous cell carcinoma of the lung.
    Zhang D; Takigawa N; Ochi N; Tanimoto Y; Noujima D; Chen YY; Tanimoto M; Kiura K
    Lung Cancer; 2011 Sep; 73(3):379-80. PubMed ID: 21684624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic accuracy of breath tests for pneumoconiosis using an electronic nose.
    Yang HY; Peng HY; Chang CJ; Chen PC
    J Breath Res; 2017 Nov; 12(1):016001. PubMed ID: 28795953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of breath-prints for the COPD detection associated with smoking and household air pollution by electronic nose.
    Rodríguez-Aguilar M; Díaz de León-Martínez L; Gorocica-Rosete P; Padilla RP; Thirión-Romero I; Ornelas-Rebolledo O; Flores-Ramírez R
    Respir Med; 2020 Mar; 163():105901. PubMed ID: 32125969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase II study of erlotinib monotherapy in pre-treated non-small cell lung cancer without EGFR gene mutation who have never/light smoking history: re-evaluation of EGFR gene status (NEJ006/TCOG0903).
    Matsumoto Y; Maemondo M; Ishii Y; Okudera K; Demura Y; Takamura K; Kobayashi K; Morikawa N; Gemma A; Ishimoto O; Usui K; Harada M; Miura S; Fujita Y; Sato I; Saijo Y;
    Lung Cancer; 2014 Nov; 86(2):195-200. PubMed ID: 25249428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. VOC pattern recognition of lung cancer: a comparative evaluation of different dog- and eNose-based strategies using different sampling materials.
    Biehl W; Hattesohl A; Jörres RA; Duell T; Althöhn U; Koczulla AR; Schmetzer H
    Acta Oncol; 2019 Sep; 58(9):1216-1224. PubMed ID: 31311375
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.